318 related articles for article (PubMed ID: 22884417)
1. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
2. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.
Pomykala KL; Ganz PA; Bower JE; Kwan L; Castellon SA; Mallam S; Cheng I; Ahn R; Breen EC; Irwin MR; Silverman DH
Brain Imaging Behav; 2013 Dec; 7(4):511-23. PubMed ID: 23835929
[TBL] [Abstract][Full Text] [Related]
3. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors.
Kesler S; Janelsins M; Koovakkattu D; Palesh O; Mustian K; Morrow G; Dhabhar FS
Brain Behav Immun; 2013 Mar; 30 Suppl(0):S109-16. PubMed ID: 22698992
[TBL] [Abstract][Full Text] [Related]
4. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
5. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
6. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.
Patel SK; Wong AL; Wong FL; Breen EC; Hurria A; Smith M; Kinjo C; Paz IB; Kruper L; Somlo G; Mortimer JE; Palomares MR; Irwin MR; Bhatia S
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26101331
[TBL] [Abstract][Full Text] [Related]
8. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
12. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
13. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
McDonald BC; Conroy SK; Smith DJ; West JD; Saykin AJ
Brain Behav Immun; 2013 Mar; 30 Suppl(0):S117-25. PubMed ID: 22613170
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
15. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
[TBL] [Abstract][Full Text] [Related]
16. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
[TBL] [Abstract][Full Text] [Related]
17. Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients.
Bower JE; Ganz PA; Irwin MR; Cole SW; Carroll J; Kuhlman KR; Petersen L; Garet D; Asher A; Hurvitz SA; Crespi CM
JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35900175
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
Kesler SR; Blayney DW
JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
[TBL] [Abstract][Full Text] [Related]
19. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
[TBL] [Abstract][Full Text] [Related]
20. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
